Portola Pharmaceuticals Reveals Full Results Of Final Stage APEX Trial Of Betrixaban
May 27, 2016 at 09:54 AM EDT
Portola Pharmaceuticals Inc. (NASDAQ: PTLA) revealed that the full results of its pivotal final stage APEX (Acute Medically Ill VTE ...